Surgery Partners/$SGRY
13:30
09:10
04:45
00:25
20:00
1D1W1MYTD1Y5YMAX
About Surgery Partners
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.
Ticker
$SGRY
Sector
Primary listing
Industry
Health Care Providers & Services
Headquarters
Employees
15,000
ISIN
US86881A1007
Website
Surgery Partners Metrics
BasicAdvanced
$2.9B
-
-$1.53
1.94
-
Price and volume
Market cap
$2.9B
Beta
1.94
52-week high
$33.97
52-week low
$18.87
Average daily volume
1.9M
Financial strength
Current ratio
1.887
Quick ratio
0.403
Long term debt to equity
104.046
Total debt to equity
99.005
Interest coverage (TTM)
2.19%
Profitability
EBITDA (TTM)
628.7
Gross margin (TTM)
23.71%
Net profit margin (TTM)
-6.10%
Operating margin (TTM)
14.92%
Effective tax rate (TTM)
110.25%
Revenue per employee (TTM)
$210,000
Management effectiveness
Return on assets (TTM)
3.97%
Return on equity (TTM)
-0.35%
Valuation
Price to revenue (TTM)
0.894
Price to book
1.64
Price to tangible book (TTM)
-0.83
Price to free cash flow (TTM)
16.373
Free cash flow yield (TTM)
6.11%
Free cash flow per share (TTM)
137.24%
Growth
Revenue change (TTM)
13.54%
Earnings per share change (TTM)
-32,214.13%
3-year revenue growth (CAGR)
11.18%
10-year revenue growth (CAGR)
19.29%
3-year earnings per share growth (CAGR)
48.57%
What the Analysts think about Surgery Partners
Analyst ratings (Buy, Hold, Sell) for Surgery Partners stock.
Bulls say / Bears say
Bain Capital's proposal to acquire the remaining shares of Surgery Partners at a 21.2% premium indicates strong confidence in the company's value and future prospects. (Reuters)
Analysts have set an average 12-month price target of $33.56 for Surgery Partners, suggesting potential upside from current levels. (MarketBeat)
The company's focus on outpatient surgical services positions it well to benefit from the ongoing industry shift towards cost-effective ambulatory surgical centers. (Investing.com)
Surgery Partners reported a net loss of $193.40 million over the trailing twelve months, raising concerns about its profitability. (StockAnalysis.com)
KeyBanc Capital Markets maintained a 'Sector Weight' rating on the stock, indicating expectations of average performance relative to the sector. (Investing.com)
The stock has shown significant volatility, with a beta of 2.40, suggesting higher risk compared to the broader market. (MarketBeat)
Data summarised monthly by Lightyear AI. Last updated on 11 Jul 2025.
Surgery Partners Financial Performance
Revenues and expenses
Surgery Partners Earnings Performance
Company profitability
Surgery Partners News
AllArticlesVideos
Surgery Partners rejects Bain Capital's take-private offer
Reuters·4 weeks ago
Surgery Partners, Inc. Announces First Quarter 2025 Results; Reaffirms Full Year 2025 Guidance
GlobeNewsWire·2 months ago
Advanced Aesthetics Plastic Surgery Partners with Ascend Aesthetic Partners to Strengthen a Collaborative Community Focused on Growth, Learning, and Patient Care
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Surgery Partners stock?
Surgery Partners (SGRY) has a market cap of $2.9B as of July 15, 2025.
What is the P/E ratio for Surgery Partners stock?
The price to earnings (P/E) ratio for Surgery Partners (SGRY) stock is 0 as of July 15, 2025.
Does Surgery Partners stock pay dividends?
No, Surgery Partners (SGRY) stock does not pay dividends to its shareholders as of July 15, 2025.
When is the next Surgery Partners dividend payment date?
Surgery Partners (SGRY) stock does not pay dividends to its shareholders.
What is the beta indicator for Surgery Partners?
Surgery Partners (SGRY) has a beta rating of 1.94. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.